 | • レポートコード：D0804-16542 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、呼吸器系抗ウイルス薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。呼吸器系抗ウイルス薬の種類別市場規模（ヌクレオシド類似体、ノイラミニダーゼ阻害剤、イオンチャネルブロッカー、融合タンパク質阻害剤）、用途別市場規模（上気道感染症（URTIs）、インフルエンザ、細気管支炎、肺炎、麻疹、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Roche、Merck、Boehringer Ingelheim、Pfizer、AstraZeneca、Johnson & Johnson、Beximco Pharmaceuticals、Novartis、Bristol-Myers Squibb Company、AbbVie Inc.、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・呼吸器系抗ウイルス薬の北米市場（アメリカ、カナダ、メキシコ） ・呼吸器系抗ウイルス薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・呼吸器系抗ウイルス薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・呼吸器系抗ウイルス薬の南米市場（ブラジル、アルゼンチン） ・呼吸器系抗ウイルス薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヌクレオシド類似体、ノイラミニダーゼ阻害剤、イオンチャネルブロッカー、融合タンパク質阻害剤 ・用途別分析：上気道感染症（URTIs）、インフルエンザ、細気管支炎、肺炎、麻疹、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Respiratory Antivirals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Respiratory Antivirals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Respiratory Antivirals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Respiratory Antivirals market has been segmented into:
Nucleoside Analogs
Neuraminidase Inhibitors
Ion Channel Blockers
Fusion Protein Inhibitors
By Application, Respiratory Antivirals has been segmented into:
Upper Respiratory Tract Infections (URTIs)
Influenza
Bronchiolitis
Pneumonia
Measles
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Respiratory Antivirals market presented in the report. This section sheds light on the sales growth of different regional and country-level Respiratory Antivirals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Respiratory Antivirals market.
The report offers in-depth assessment of the growth and other aspects of the Respiratory Antivirals market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Respiratory Antivirals Market Share Analysis
Respiratory Antivirals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Respiratory Antivirals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Respiratory Antivirals sales, revenue and market share for each player covered in this report.
The major players covered in Respiratory Antivirals are:
GSK
Roche
Merck
Boehringer Ingelheim
Pfizer
AstraZeneca
Johnson & Johnson
Beximco Pharmaceuticals
Novartis
Bristol-Myers Squibb Company
AbbVie Inc.
Sanofi
1 Respiratory Antivirals Market Overview
1.1 Product Overview and Scope of Respiratory Antivirals
1.2 Classification of Respiratory Antivirals by Type
1.2.1 Global Respiratory Antivirals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Respiratory Antivirals Revenue Market Share by Type in 2019
1.2.3 Nucleoside Analogs
1.2.4 Neuraminidase Inhibitors
1.2.5 Ion Channel Blockers
1.2.6 Fusion Protein Inhibitors
1.3 Global Respiratory Antivirals Market by Application
1.3.1 Overview: Global Respiratory Antivirals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Upper Respiratory Tract Infections (URTIs)
1.3.3 Influenza
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Measles
1.3.7 Others
1.4 Global Respiratory Antivirals Market by Regions
1.4.1 Global Respiratory Antivirals Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Respiratory Antivirals (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Respiratory Antivirals Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Respiratory Antivirals Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Respiratory Antivirals Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Respiratory Antivirals Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Respiratory Antivirals Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beximco Pharmaceuticals
2.8.1 Beximco Pharmaceuticals Details
2.8.2 Beximco Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beximco Pharmaceuticals SWOT Analysis
2.8.4 Beximco Pharmaceuticals Product and Services
2.8.5 Beximco Pharmaceuticals Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb Company
2.10.1 Bristol-Myers Squibb Company Details
2.10.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb Company SWOT Analysis
2.10.4 Bristol-Myers Squibb Company Product and Services
2.10.5 Bristol-Myers Squibb Company Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.11 AbbVie Inc.
2.11.1 AbbVie Inc. Details
2.11.2 AbbVie Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 AbbVie Inc. SWOT Analysis
2.11.4 AbbVie Inc. Product and Services
2.11.5 AbbVie Inc. Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sanofi SWOT Analysis
2.12.4 Sanofi Product and Services
2.12.5 Sanofi Respiratory Antivirals Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Respiratory Antivirals Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Respiratory Antivirals Players Market Share
3.2.2 Top 10 Respiratory Antivirals Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Respiratory Antivirals Revenue and Market Share by Regions
4.2 North America Respiratory Antivirals Revenue and Growth Rate (2015-2020)
4.3 Europe Respiratory Antivirals Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Respiratory Antivirals Revenue and Growth Rate (2015-2020)
4.5 South America Respiratory Antivirals Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Respiratory Antivirals Revenue and Growth Rate (2015-2020)
5 North America Respiratory Antivirals Revenue by Countries
5.1 North America Respiratory Antivirals Revenue by Countries (2015-2020)
5.2 USA Respiratory Antivirals Revenue and Growth Rate (2015-2020)
5.3 Canada Respiratory Antivirals Revenue and Growth Rate (2015-2020)
5.4 Mexico Respiratory Antivirals Revenue and Growth Rate (2015-2020)
6 Europe Respiratory Antivirals Revenue by Countries
6.1 Europe Respiratory Antivirals Revenue by Countries (2015-2020)
6.2 Germany Respiratory Antivirals Revenue and Growth Rate (2015-2020)
6.3 UK Respiratory Antivirals Revenue and Growth Rate (2015-2020)
6.4 France Respiratory Antivirals Revenue and Growth Rate (2015-2020)
6.5 Russia Respiratory Antivirals Revenue and Growth Rate (2015-2020)
6.6 Italy Respiratory Antivirals Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Respiratory Antivirals Revenue by Countries
7.1 Asia-Pacific Respiratory Antivirals Revenue by Countries (2015-2020)
7.2 China Respiratory Antivirals Revenue and Growth Rate (2015-2020)
7.3 Japan Respiratory Antivirals Revenue and Growth Rate (2015-2020)
7.4 Korea Respiratory Antivirals Revenue and Growth Rate (2015-2020)
7.5 India Respiratory Antivirals Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Respiratory Antivirals Revenue and Growth Rate (2015-2020)
8 South America Respiratory Antivirals Revenue by Countries
8.1 South America Respiratory Antivirals Revenue by Countries (2015-2020)
8.2 Brazil Respiratory Antivirals Revenue and Growth Rate (2015-2020)
8.3 Argentina Respiratory Antivirals Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Respiratory Antivirals by Countries
9.1 Middle East & Africa Respiratory Antivirals Revenue by Countries (2015-2020)
9.2 Saudi Arabia Respiratory Antivirals Revenue and Growth Rate (2015-2020)
9.3 UAE Respiratory Antivirals Revenue and Growth Rate (2015-2020)
9.4 Egypt Respiratory Antivirals Revenue and Growth Rate (2015-2020)
9.5 South Africa Respiratory Antivirals Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Respiratory Antivirals Revenue and Market Share by Type (2015-2020)
10.2 Global Respiratory Antivirals Market Forecast by Type (2019-2024)
10.3 Nucleoside Analogs Revenue Growth Rate (2015-2025)
10.4 Neuraminidase Inhibitors Revenue Growth Rate (2015-2025)
10.5 Ion Channel Blockers Revenue Growth Rate (2015-2025)
10.6 Fusion Protein Inhibitors Revenue Growth Rate (2015-2025)
11 Global Respiratory Antivirals Market Segment by Application
11.1 Global Respiratory Antivirals Revenue Market Share by Application (2015-2020)
11.2 Respiratory Antivirals Market Forecast by Application (2019-2024)
11.3 Upper Respiratory Tract Infections (URTIs) Revenue Growth (2015-2020)
11.4 Influenza Revenue Growth (2015-2020)
11.5 Bronchiolitis Revenue Growth (2015-2020)
11.6 Pneumonia Revenue Growth (2015-2020)
11.7 Measles Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Respiratory Antivirals Market Size Forecast (2021-2025)
12.1 Global Respiratory Antivirals Market Size Forecast (2021-2025)
12.2 Global Respiratory Antivirals Market Forecast by Regions (2021-2025)
12.3 North America Respiratory Antivirals Revenue Market Forecast (2021-2025)
12.4 Europe Respiratory Antivirals Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Respiratory Antivirals Revenue Market Forecast (2021-2025)
12.6 South America Respiratory Antivirals Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Respiratory Antivirals Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Respiratory Antivirals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Respiratory Antivirals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Respiratory Antivirals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Respiratory Antivirals Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Respiratory Antivirals Major Business
Table 7. GSK Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Respiratory Antivirals Product and Solutions
Table 10. GSK Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Corporate Information, Location and Competitors
Table 12. Roche Respiratory Antivirals Major Business
Table 13. Roche Respiratory Antivirals Total Revenue (USD Million) (2018-2019)
Table 14. Roche SWOT Analysis
Table 15. Roche Respiratory Antivirals Product and Solutions
Table 16. Roche Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Respiratory Antivirals Major Business
Table 19. Merck Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Respiratory Antivirals Product and Solutions
Table 22. Merck Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 24. Boehringer Ingelheim Respiratory Antivirals Major Business
Table 25. Boehringer Ingelheim Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 26. Boehringer Ingelheim SWOT Analysis
Table 27. Boehringer Ingelheim Respiratory Antivirals Product and Solutions
Table 28. Boehringer Ingelheim Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Respiratory Antivirals Major Business
Table 31. Pfizer Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Respiratory Antivirals Product and Solutions
Table 34. Pfizer Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca Respiratory Antivirals Major Business
Table 37. AstraZeneca Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Respiratory Antivirals Product and Solutions
Table 40. AstraZeneca Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Johnson & Johnson Corporate Information, Location and Competitors
Table 42. Johnson & Johnson Respiratory Antivirals Major Business
Table 43. Johnson & Johnson Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 44. Johnson & Johnson SWOT Analysis
Table 45. Johnson & Johnson Respiratory Antivirals Product and Solutions
Table 46. Johnson & Johnson Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beximco Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Beximco Pharmaceuticals Respiratory Antivirals Major Business
Table 49. Beximco Pharmaceuticals Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 50. Beximco Pharmaceuticals SWOT Analysis
Table 51. Beximco Pharmaceuticals Respiratory Antivirals Product and Solutions
Table 52. Beximco Pharmaceuticals Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis Corporate Information, Location and Competitors
Table 54. Novartis Respiratory Antivirals Major Business
Table 55. Novartis Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 56. Novartis SWOT Analysis
Table 57. Novartis Respiratory Antivirals Product and Solutions
Table 58. Novartis Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Company Respiratory Antivirals Major Business
Table 61. Bristol-Myers Squibb Company Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb Company SWOT Analysis
Table 63. Bristol-Myers Squibb Company Respiratory Antivirals Product and Solutions
Table 64. Bristol-Myers Squibb Company Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. AbbVie Inc. Corporate Information, Location and Competitors
Table 66. AbbVie Inc. Respiratory Antivirals Major Business
Table 67. AbbVie Inc. Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 68. AbbVie Inc. SWOT Analysis
Table 69. AbbVie Inc. Respiratory Antivirals Product and Solutions
Table 70. AbbVie Inc. Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Sanofi Corporate Information, Location and Competitors
Table 72. Sanofi Respiratory Antivirals Major Business
Table 73. Sanofi Respiratory Antivirals Total Revenue (USD Million) (2017-2018)
Table 74. Sanofi SWOT Analysis
Table 75. Sanofi Respiratory Antivirals Product and Solutions
Table 76. Sanofi Respiratory Antivirals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Respiratory Antivirals Revenue (Million USD) by Players (2015-2020)
Table 78. Global Respiratory Antivirals Revenue Share by Players (2015-2020)
Table 79. Global Respiratory Antivirals Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Respiratory Antivirals Revenue Market Share by Regions (2015-2020)
Table 81. North America Respiratory Antivirals Revenue by Countries (2015-2020)
Table 82. North America Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Table 83. Europe Respiratory Antivirals Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Respiratory Antivirals Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Respiratory Antivirals Revenue by Countries (2015-2020)
Table 86. South America Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Respiratory Antivirals Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Table 89. Global Respiratory Antivirals Revenue (Million USD) by Type (2015-2020)
Table 90. Global Respiratory Antivirals Revenue Share by Type (2015-2020)
Table 91. Global Respiratory Antivirals Revenue Forecast by Type (2021-2025)
Table 92. Global Respiratory Antivirals Revenue by Application (2015-2020)
Table 93. Global Respiratory Antivirals Revenue Share by Application (2015-2020)
Table 94. Global Respiratory Antivirals Revenue Forecast by Application (2021-2025)
Table 95. Global Respiratory Antivirals Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Respiratory Antivirals Picture
Figure 2. Global Respiratory Antivirals Revenue Market Share by Type in 2019
Figure 3. Nucleoside Analogs Picture
Figure 4. Neuraminidase Inhibitors Picture
Figure 5. Ion Channel Blockers Picture
Figure 6. Fusion Protein Inhibitors Picture
Figure 7. Respiratory Antivirals Revenue Market Share by Application in 2019
Figure 8. Upper Respiratory Tract Infections (URTIs) Picture
Figure 9. Influenza Picture
Figure 10. Bronchiolitis Picture
Figure 11. Pneumonia Picture
Figure 12. Measles Picture
Figure 13. Others Picture
Figure 14. Global Respiratory Antivirals Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Respiratory Antivirals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Respiratory Antivirals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Respiratory Antivirals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Respiratory Antivirals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Respiratory Antivirals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Respiratory Antivirals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Respiratory Antivirals Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Respiratory Antivirals Revenue Market Share in 2019
Figure 23. Global Top 10 Players Respiratory Antivirals Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Respiratory Antivirals Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Respiratory Antivirals Revenue Market Share by Regions (2015-2020)
Figure 27. Global Respiratory Antivirals Revenue Market Share by Regions in 2018
Figure 28. North America Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 29. Europe Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 31. South America Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 33. North America Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Figure 34. North America Respiratory Antivirals Revenue Market Share by Countries in 2019
Figure 35. USA Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 36. Canada Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 38. Europe Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Respiratory Antivirals Revenue Market Share by Countries in 2019
Figure 40. Germany Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 41. UK Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 42. France Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 43. Russia Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 44. Italy Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Respiratory Antivirals Revenue Market Share by Countries in 2019
Figure 47. China Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 48. Japan Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 49. Korea Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 50. India Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 52. South America Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Figure 53. South America Respiratory Antivirals Revenue Market Share by Countries in 2019
Figure 54. Brazil Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Respiratory Antivirals Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Respiratory Antivirals Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 59. UAE Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Respiratory Antivirals Revenue and Growth Rate (2015-2020)
Figure 62. Global Respiratory Antivirals Revenue Share by Type (2015-2020)
Figure 63. Global Respiratory Antivirals Revenue Share by Type in 2019
Figure 64. Global Respiratory Antivirals Market Share Forecast by Type (2021-2025)
Figure 65. Global Nucleoside Analogs Revenue Growth Rate (2015-2020)
Figure 66. Global Neuraminidase Inhibitors Revenue Growth Rate (2015-2020)
Figure 67. Global Ion Channel Blockers Revenue Growth Rate (2015-2020)
Figure 68. Global Fusion Protein Inhibitors Revenue Growth Rate (2015-2020)
Figure 69. Global Respiratory Antivirals Revenue Share by Application (2015-2020)
Figure 70. Global Respiratory Antivirals Revenue Share by Application in 2019
Figure 71. Global Respiratory Antivirals Market Share Forecast by Application (2021-2025)
Figure 72. Global Upper Respiratory Tract Infections (URTIs) Revenue Growth Rate (2015-2020)
Figure 73. Global Influenza Revenue Growth Rate (2015-2020)
Figure 74. Global Bronchiolitis Revenue Growth Rate (2015-2020)
Figure 75. Global Pneumonia Revenue Growth Rate (2015-2020)
Figure 76. Global Measles Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Respiratory Antivirals Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Respiratory Antivirals Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Respiratory Antivirals Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Respiratory Antivirals Revenue Market Forecast (2021-2025)
Figure 82. Europe Respiratory Antivirals Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Respiratory Antivirals Revenue Market Forecast (2021-2025)
Figure 84. South America Respiratory Antivirals Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Respiratory Antivirals Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
抗ウイルス剤の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Antivirals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 53380 million by 2025, from USD 45100 million in 2019. The Antivirals market report pr…- 呼吸器用アナライザーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Respiratory Analyzer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 呼吸器用測定装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Respiratory Measurement Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory M…
- 呼吸用人工呼吸器試験機の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Respiratory Ventilator Tester market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 呼吸器病原体検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Respiratory Pathogen Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Path…